Is Teladoc Stock a Smart Buy After Q3 Earnings?
Teladoc Health (NYSE: TDOC) became a household name during the pandemic, when its telemedicine platform saw widespread adoption. However, membership growth has slowed in 2021 and the stock has been pummeled, falling nearly 50% from its all-time high.
In this Backstage Pass video, which aired Oct. 27, 2021, Motley Fool contributor Rachel Warren discusses Teladoc's third-quarter earnings, and explains why she still has long-term conviction in the company. Fool contributor Brian Withers is also in this clip.
Source Fool.com
